BenjaminDobrzanski

Inhibitor of JAK2 CEP-33779, a Novel, Orally Active, Selective Treatment of Lupus Nephritis in Mice Using Depletion of Autoreactive Plasma Cells and

Mason, B. Ruggeri, D. Gingrich, 2011 .